Intra-Cellular Therapies Inc Logo Image

Intra-Cellular Therapies Inc

Intra-Cellular Therapies Inc Banner Image

Most Recent Annual Report

2019 Annual Report and Form 10K

Intra-Cellular Therapies Inc

Intra-Cellular Therapies Inc does not currently have any hardcopy reports on Click the button below to request a report when hardcopies become available.

Archived Annual Reports

About Intra-Cellular Therapies Inc

51-200 Employees
Based in New York City, New York

Intra-Cellular Therapies, Inc., a biopharmaceutical company, discovers and develops small molecule drugs for the treatment of neuropsychiatric and neurologic disorders within the central nervous system (CNS). Its lead drug candidate is ITI-007, which is in phase III clinical development for the treatment of schizophrenia, behavioral disturbances in dementia, bipolar disorder, depression, and other neuropsychiatric and neurological disorders.

NASDAQ (See More NASDAQ Companies)
Biotechnology (See More Biotechnology Companies)
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol